AtlasWho We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Trait
Hallucinations
Perceptions in a conscious and awake state that, in the absence of external stimuli, have qualities of real perception. These perceptions are vivid, substantial, and located in external objective space.
Summary
- Also called
- Hallucination, Sensory hallucination
- Body system
- Abnormality of the nervous system
AtlasWho We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
This page as data
Add .json to the page's address, or ask for application/json, to read it as JSON.
library(jsonlite)
url <- "https://dantelabs.com/traits/hallucinations.json"
page <- fromJSON(url)
page$trait$nameHallucinationsHP:0000738
AtlasWho We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Read the genes linked to Hallucinations, and the rest of your genome, with one test.
From $449Free shipping · Results in 6–8 weeks
Get my Genome Test117 genes linked to Hallucinations
Changes in these genes cause rare conditions in which Hallucinations is seen. Most people with this trait have none of those conditions, and a gene on this list says nothing about anyone's own genome.
| Gene | How often it is seen | Conditions |
|---|---|---|
| GCSHglycine cleavage system protein H | Always | In 1 condition |
| HTRA1HtrA serine peptidase 1 | Always | In 1 condition |
| LRRC7leucine rich repeat containing 7 | Always | In 1 condition |
| RAB3ARAB3A, member RAS oncogene family | Always | In 1 condition |
| TRRAPtransformation/transcription domain associated protein | Always | In 1 condition |
| APPamyloid beta precursor protein | Very often (80–99%) | In 1 condition |
| CLTRNcollectrin, amino acid transport regulator | Very often (80–99%) | In 1 condition |
| CTSHcathepsin H | Very often (80–99%) | In 1 condition |
| HCRThypocretin neuropeptide precursor | Very often (80–99%) | In 2 conditions |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Very often (80–99%) | In 3 conditions |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Very often (80–99%) | In 2 conditions |
| MOGmyelin oligodendrocyte glycoprotein | Very often (80–99%) | In 1 condition |
| P2RY11purinergic receptor P2Y11 | Very often (80–99%) | In 1 condition |
| PSEN1presenilin 1 | Very often (80–99%) | In 1 condition |
| PSEN2presenilin 2 | Very often (80–99%) | In 1 condition |
| SLC6A19solute carrier family 6 member 19 | Very often (80–99%) | In 1 condition |
| SORL1sortilin related receptor 1 | Very often (80–99%) | In 1 condition |
| TNFSF4TNF superfamily member 4 | Very often (80–99%) | In 1 condition |
| TOMM40translocase of outer mitochondrial membrane 40 | Very often (80–99%) | In 1 condition |
| TREM2triggering receptor expressed on myeloid cells 2 | Very often (80–99%) | In 1 condition |
| ZNF365zinc finger protein 365 | Very often (80–99%) | In 2 conditions |
| ARSAarylsulfatase A | Often (30–79%) | In 4 conditions |
| ATP13A2ATPase cation transporting 13A2 | Often (30–79%) | In 3 conditions |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Often (30–79%) | In 1 condition |
| DNAJC6DnaJ heat shock protein family (Hsp40) member C6 | Often (30–79%) | In 2 conditions |
| EPG5ectopic P-granules 5 autophagy tethering factor | Often (30–79%) | In 1 condition |
| FUSFUS RNA binding protein | Often (30–79%) | In 1 condition |
| HTRA2HtrA serine peptidase 2 | Often (30–79%) | In 1 condition |
| HTThuntingtin | Often (30–79%) | In 1 condition |
| LRRK2leucine rich repeat kinase 2 | Often (30–79%) | In 1 condition |
| PARK7Parkinsonism associated deglycase | Often (30–79%) | In 1 condition |
| PINK1PTEN induced kinase 1 | Often (30–79%) | In 1 condition |
| PODXLpodocalyxin like | Often (30–79%) | In 1 condition |
| PRKNparkin RBR E3 ubiquitin protein ligase | Often (30–79%) | In 1 condition |
| PRNPprion protein (Kanno blood group) | Often (30–79%) | In 3 conditions |
| PSAPprosaposin | Often (30–79%) | In 3 conditions |
| RAB32RAB32, member RAS oncogene family | Often (30–79%) | In 1 condition |
| SLC25A13solute carrier family 25 member 13 | Often (30–79%) | In 1 condition |
| SLC2A3solute carrier family 2 member 3 | Often (30–79%) | In 1 condition |
| SNCAsynuclein alpha | Often (30–79%) | In 3 conditions |
Show 77 more genes
| Gene | How often it is seen | Conditions |
|---|---|---|
| SQSTM1sequestosome 1 | Often (30–79%) | In 1 condition |
| SYNJ1synaptojanin 1 | Often (30–79%) | In 1 condition |
| TARDBPTAR DNA binding protein | Often (30–79%) | In 1 condition |
| TBK1TANK binding kinase 1 | Often (30–79%) | In 1 condition |
| UCHL1ubiquitin C-terminal hydrolase L1 | Often (30–79%) | In 1 condition |
| VCPvalosin containing protein | Often (30–79%) | In 1 condition |
| VPS13Cvacuolar protein sorting 13 homolog C | Often (30–79%) | In 2 conditions |
| ADH1Calcohol dehydrogenase 1C (class I), gamma polypeptide | Sometimes (5–29%) | In 1 condition |
| ALADaminolevulinate dehydratase | Sometimes (5–29%) | In 1 condition |
| ALDH4A1aldehyde dehydrogenase 4 family member A1 | Sometimes (5–29%) | In 1 condition |
| ATMATM serine/threonine kinase | Sometimes (5–29%) | In 1 condition |
| ATP7BATPase copper transporting beta | Sometimes (5–29%) | In 1 condition |
| ATXN2ataxin 2 | Sometimes (5–29%) | In 1 condition |
| ATXN3ataxin 3 | Sometimes (5–29%) | In 1 condition |
| ATXN8OSATXN8 opposite strand lncRNA | Sometimes (5–29%) | In 1 condition |
| BMPR1Abone morphogenetic protein receptor type 1A | Sometimes (5–29%) | In 1 condition |
| BPTFbromodomain PHD finger transcription factor | Sometimes (5–29%) | In 1 condition |
| BRCA2BRCA2 DNA repair associated | Sometimes (5–29%) | In 1 condition |
| CHEK2checkpoint kinase 2 | Sometimes (5–29%) | In 1 condition |
| CISD2CDGSH iron sulfur domain 2 | Sometimes (5–29%) | In 1 condition |
| CYP27A1cytochrome P450 family 27 subfamily A member 1 | Sometimes (5–29%) | In 2 conditions |
| DCAF17DDB1 and CUL4 associated factor 17 | Sometimes (5–29%) | In 2 conditions |
| EPCAMepithelial cell adhesion molecule | Sometimes (5–29%) | In 1 condition |
| GBA1glucosylceramidase beta 1 | Sometimes (5–29%) | In 1 condition |
| HMBShydroxymethylbilane synthase | Sometimes (5–29%) | In 1 condition |
| KRASKRas proto-oncogene, GTPase | Sometimes (5–29%) | In 1 condition |
| MAN2B1mannosidase alpha class 2B member 1 | Sometimes (5–29%) | In 2 conditions |
| MAPTmicrotubule associated protein tau | Sometimes (5–29%) | In 1 condition |
| MED12mediator complex subunit 12 | Sometimes (5–29%) | In 1 condition |
| MLH1mutL homolog 1 | Sometimes (5–29%) | In 1 condition |
| MSH2mutS homolog 2 | Sometimes (5–29%) | In 1 condition |
| MSH6mutS homolog 6 | Sometimes (5–29%) | In 1 condition |
| MT-TTmitochondrially encoded tRNA-Thr (ACN) | Sometimes (5–29%) | In 1 condition |
| MUTYHmutY DNA glycosylase | Sometimes (5–29%) | In 1 condition |
| NDPnorrin cystine knot growth factor NDP | Sometimes (5–29%) | In 2 conditions |
| NPATnuclear protein, coactivator of histone transcription | Sometimes (5–29%) | In 1 condition |
| NR4A2nuclear receptor subfamily 4 group A member 2 | Sometimes (5–29%) | In 1 condition |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Sometimes (5–29%) | In 1 condition |
| PMS1PMS1 homolog 1, mismatch repair system component | Sometimes (5–29%) | In 1 condition |
| PMS2PMS1 homolog 2, mismatch repair system component | Sometimes (5–29%) | In 1 condition |
| POLD1DNA polymerase delta 1, catalytic subunit | Sometimes (5–29%) | In 1 condition |
| POLEDNA polymerase epsilon, catalytic subunit | Sometimes (5–29%) | In 1 condition |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Sometimes (5–29%) | In 1 condition |
| RPS20ribosomal protein S20 | Sometimes (5–29%) | In 1 condition |
| SEMA4Asemaphorin 4A | Sometimes (5–29%) | In 1 condition |
| SNCAIPsynuclein alpha interacting protein | Sometimes (5–29%) | In 1 condition |
| SPARTspartin | Sometimes (5–29%) | In 1 condition |
| TBPTATA-box binding protein | Sometimes (5–29%) | In 2 conditions |
| TGFBR2transforming growth factor beta receptor 2 | Sometimes (5–29%) | In 1 condition |
| TTRtransthyretin | Sometimes (5–29%) | In 1 condition |
| UPF3BUPF3B regulator of nonsense mediated mRNA decay | Sometimes (5–29%) | In 1 condition |
| WFS1wolframin ER transmembrane glycoprotein | Sometimes (5–29%) | In 1 condition |
| ZDHHC9zDHHC palmitoyltransferase 9 | Sometimes (5–29%) | In 1 condition |
| DNM1Ldynamin 1L | Rarely (1–4%) | In 1 condition |
| OPA1OPA1 mitochondrial dynamin like GTPase | Rarely (1–4%) | In 1 condition |
| PPIBpeptidylprolyl isomerase B | Rarely (1–4%) | In 1 condition |
| PPOXprotoporphyrinogen oxidase | Rarely (1–4%) | In 1 condition |
| ALDH5A1aldehyde dehydrogenase 5 family member A1 | Not recorded | In 1 condition |
| APOL2apolipoprotein L2 | Not recorded | In 1 condition |
| BCKDHAbranched chain keto acid dehydrogenase E1 subunit alpha | Not recorded | In 1 condition |
| BCS1LBCS1 ubiquinol-cytochrome c reductase complex chaperone | Not recorded | In 1 condition |
| C9orf72C9orf72-SMCR8 complex subunit | Not recorded | In 1 condition |
| CHI3L1chitinase 3 like 1 | Not recorded | In 1 condition |
| CPOXcoproporphyrinogen oxidase | Not recorded | In 1 condition |
| DAOAD-amino acid oxidase activator | Not recorded | In 1 condition |
| DISC2disrupted in schizophrenia 2 | Not recorded | In 1 condition |
| DRD3dopamine receptor D3 | Not recorded | In 1 condition |
| ECM1extracellular matrix protein 1 | Not recorded | In 1 condition |
| GRNgranulin precursor | Not recorded | In 1 condition |
| HTR2A5-hydroxytryptamine receptor 2A | Not recorded | In 1 condition |
| JPH3junctophilin 3 | Not recorded | In 1 condition |
| MTHFRmethylenetetrahydrofolate reductase | Not recorded | In 1 condition |
| PPT1palmitoyl-protein thioesterase 1 | Not recorded | In 1 condition |
| PRDM8PR/SET domain 8 | Not recorded | In 1 condition |
| RTN4Rreticulon 4 receptor | Not recorded | In 1 condition |
| SYN2synapsin II | Not recorded | In 1 condition |
| TTC19tetratricopeptide repeat domain 19 | Not recorded | In 1 condition |
How often is among people with one of the gene's conditions, the most often across them, as the Human Phenotype Ontology records it. These pages describe traits and the research behind them; they are not a diagnosis, and a doctor or genetic counsellor is the person to ask about symptoms.
Narrower traits
Broader traits
Where this comes from
- The Human Phenotype Ontology, release 2026-09-01: the trait, its names, its definition and the genes linked to it. Find out more at hpo.jax.org.
- Data release 2026.10.16-c6eea6bf.
AtlasWho We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
One test. A lifetime of answers.
From $449Free shipping · Results in 6–8 weeks